Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perianal dexmedetomidine vs ketamine for postoperative pain and vomiting after perianal fistula surgery
IRCT20230912059416N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and ketamine in acute postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Postoperative pain intensity and Postoperative vomiting. Started Dec 2023; status: completed.
02
Drugs
dexmedetomidineketamine
03
Conditions
acute postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20230912059416N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230912059416N1.